KASINGER JAMES R. (CIK 1708172) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-24). Recent activity: Buy CRSP (10,400 shares), Sell CRSP (10,400 shares), Buy CRSP (6,250 shares), Sell CRSP (3,182 shares), Buy CRSP (6,875 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-24 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | Buy | 10,400 | $141,648 |
| 2026-09-24 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | Sell | 10,400 | $626,460 |
| 2026-03-24 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | Buy | 6,250 | $0 |
| 2026-03-24 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | Sell | 3,182 | $148,854 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | Buy | 6,875 | $0 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | Sell | 3,450 | $166,497 |
| 2026-03-12 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | Buy | 5,500 | $0 |
| 2026-03-12 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | Sell | 2,800 | $147,840 |
| 2026-02-20 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | Buy | 3,825 | $0 |
| 2026-02-20 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | Sell | 2,112 | $111,049 |
| 2025-10-15 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | Buy | 2,114 | $0 |
| 2025-10-15 | CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | Sell | 1,076 | $71,662 |
来源：SEC Form 4 申报文件 · 截至 2026-09-24